Home › Head and Neck Cancer › NCT03483337
New MRI Biomarkers in Head and Neck Cancers
Quantitative Imaging Tools to Derive DW-MRI Oncological Biomarkers
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Age ≥ 18 years * Group 1 patients: Presence of a suspicious metastatic lesion or suspicious for recurrent disease in the head and neck region. * Group 2 patients: * Biopsy proven recurrent or metastatic or definitive head and neck cancer or (differentiated and undifferentiated) thyroid cancers in the head and neck region only. * Patients planning to undergo reatment at MSK Exclusion Criteria: * Patient would require anesthesia for the study * Patients who are claustrophobic * Patients selecting treatment outside of MSK * Known reaction to Gd based contrast agent * Patients who have presence of a known contradiction to MRI * Pacemaker * Aneurysm clips * Patients with implants that are contradicted for MR imaging will be excluded * Pregnant * Age and mental status wherein he /she is unable to cooperate for MRI study
About the study
Magnetic resonance imaging (MRI) is a diagnostic technique that takes pictures of organs of the body. It uses magnetic fields and radio waves that cannot be felt. This makes specific organs, blood vessels, or tumors easier to see. Diffusion MRI lets us measure the motion of water in the tumor.
The purpose of this study is to see if new MRI methods can give us more information about the tumor.
What is being tested
- MRI examinations (other)
- MRI examinations (other)
Sponsor: Memorial Sloan Kettering Cancer Center · Participants: 200 · Started: Mar 16, 2018
Contact the study team
- Amita Dave, PhD · Phone: 212-639-3184
- Alan Ho, MD, PhD · Phone: 646-608-3774
Official record on ClinicalTrials.gov — NCT03483337
Locations in the U.S.
| New York | Memorial Sloan Kettering Cancer Center, New York |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.